BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 9, 2013
View Archived Issues
RNA interference-based nanoparticles to treat brain tumors
Read More
FDA accepts IND application for Gencaro in atrial fibrillation
Read More
Novel V1B receptor antagonists demonstrate activity in animal models of anxiety and depression
Read More
Mesoblast reports topline data from phase II study of MPCs in type 2 diabetes
Read More
FDA grants isavuconazole QIDP designation in invasive aspergillosis
Read More
MUC-1 cancer vaccine well tolerated in phase I study
Read More
Mylan acquires Agila injectables businesses from Strides Arcolab
Read More
Novartis presents novel tyrosine-protein kinase inhibitors
Read More
Edivoxetine does not meet endpoint in phase III studies in major depressive disorder
Read More
Gilead Sciences discloses novel antiviral compounds
Read More
Receptos to begin phase III part of RPC-1063 study in relapsing multiple sclerosis
Read More
Phase Ib data for MP-4-CO in patients with sickle cell anemia
Read More
Chinese group prepares new protein kinase inhibitors
Read More
FDA grants orphan drug status to KX-02 for gliomas
Read More
Actelion Pharmaceuticals synthesizes novel LXA4 receptor agonists
Read More
Ortho-McNeil-Janssen Pharmaceuticals divulges novel agents for Alzheimer's disease
Read More
Sanofi and Hanmi launch Robelito in Korea
Read More
Amgen reports new glucokinase activators for diabetes and other disorders
Read More
ALS Therapy Development Institute and Neurimmune establish research partnership
Read More
FDA approves Xiaflex for Peyronie's disease
Read More
European approval for Fluenz Tetra
Read More
DX-2930 receives FDA orphan drug designation in hereditary angioedema
Read More
FDA approves Sovaldi for chronic hepatitis C
Read More
ViiV Healthcare seeks approval for dolutegravir in Japan
Read More
Synflorix approved in Europe for immunization against pneumonia in infants and children
Read More
Ikervis MAA filed in Europe for dry eye disease
Read More
European submission of safinamide for Parkinson's disease
Read More